Harlan W. Waksal
2022 - Lyra Therapeutics
In 2022, Harlan W. Waksal earned a total compensation of $5M as Executive Chairman at Lyra Therapeutics.
Compensation breakdown
| Option Awards | $4,839,974 |
|---|---|
| Salary | $175,385 |
| Other | $12,016 |
| Total | $5,027,375 |
Waksal received $4.8M in option awards, accounting for 96% of the total pay in 2022.
Waksal also received $175.4K in salary and $12K in other compensation.
Rankings
In 2022, Harlan W. Waksal's compensation ranked 631st out of 5,739 executives tracked by ExecPay. In other words, Waksal earned more than 89.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 631 out of 5,739 | 89th |
Division Manufacturing | 273 out of 3,128 | 91st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 23 out of 485 | 95th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 15 out of 347 | 96th |
Industry Surgical and Medical Instruments and Apparatus | 13 out of 253 | 95th |
Source: SEC filing on April 25, 2023.
Waksal's colleagues
We found two more compensation records of executives who worked with Harlan W. Waksal at Lyra Therapeutics in 2022.
News
Lyra Therapeutics Chairman Harlan Waksal receives $5M in 2022
April 25, 2023
Kadmon Holdings CFO Steven Meehan's 2020 pay jumps 76% to $2.3M
April 1, 2021
Kadmon Holdings CEO Harlan Waksal's 2019 pay jumps 27% to $4.7M
April 2, 2020
Kadmon Holdings CEO Harlan Waksal's 2018 pay jumps 43% to $3.7M
April 2, 2019